Search
Black Diamond Therapeutics Inc
BDTXAdd to Watchlist
1.880USD
-0.020-1.05%
Market hours 09/24, 12:18（ET）
107.72MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.05%
5 Days
-3.09%
1 Month
-14.93%
6 Months
-12.56%
Year to Date
-22.63%
1 Year
-40.69%
Key Figures
1.923Open
1.970High
40.53KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.07%Turnover Ratio
1.900Prev. Close
1.830Low
75.46KTurnover
LossP/E Static
1.12P/B
0.00%Div Yield TTM
-27.95%ROA
4.94052wk High
0.12Volume Ratio
-69.68MNet Profit
57.30MShares
-0.7624EPS TTM
3.25Beta
-35.16%ROE
1.60052wk Low
7.37%Amplitude
100.00%Gross Margin
107.72MMarket Cap
2.46Reward/Risk
5.17%Risk Rate
More news coming soon, stay tuned...
Black Diamond Therapeutics Inc's Score
0.02vs previous score
Forecast8.44
Financial Health9.23
Technical4.04
Valuation Dimensions6.79
Institutional Confidence7.00
Risk Assessment3.47
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Black Diamond Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.17/-0.20
Revenue / Forecast
0.00/0.00
Black Diamond Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolBDTX
Number of employees24
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| T. Rowe Price Investment Management, Inc. | 18.51% |
| Versant Ventures | 10.83% |
| New Enterprise Associates (NEA) | 7.76% |
| Acadian Asset Management LLC | 2.84% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 28.81% |
| Venture Capital | 18.80% |
| Investment Advisor/Hedge Fund | 17.54% |
| Hedge Fund | 6.36% |
Related Instruments
+3.79%
+0.54%
-0.25%
+0.78%
+0.87%
+1.55%
+0.01%
-0.17%
+0.77%
+1.35%
+1.42%
-0.52%
+0.14%
+0.34%
-1.18%
-0.66%
+2.33%
+0.97%
-0.98%
+1.35%Popular Instruments
51385.400
-104.600 (-0.20%)
30383.300
-94.600 (-0.31%)
7696.800
-10.200 (-0.13%)
14276.000
-146.000 (-1.01%)
65853.000
-276.000 (-0.42%)
6313.700
+23.700 (+0.38%)
93.923
+1.433 (+1.55%)
338.230
+1.210 (+0.36%)
223.560
-1.950 (-0.86%)
4275.370
-10.870 (-0.25%)
FAQs
What is the current price of Black Diamond Therapeutics Inc (BDTX)?
The current price of Black Diamond Therapeutics Inc (BDTX) is 1.90.
What is the symbol of Black Diamond Therapeutics Inc?
The ticker symbol of Black Diamond Therapeutics Inc is BDTX.
What is the 52-week high of Black Diamond Therapeutics Inc?
The 52-week high of Black Diamond Therapeutics Inc is 4.94.
What is the 52-week low of Black Diamond Therapeutics Inc?
The 52-week low of Black Diamond Therapeutics Inc is 1.60.
What is the market capitalization of Black Diamond Therapeutics Inc?
The market capitalization of Black Diamond Therapeutics Inc is 108.87M.
Is Black Diamond Therapeutics Inc (BDTX) currently rated as Buy, Hold, or Sell?
According to analysts, Black Diamond Therapeutics Inc (BDTX) has an overall rating of Buy, with a price target of 10.00.
What is the Earnings Per Share (EPS TTM) of Black Diamond Therapeutics Inc (BDTX)?
The Earnings Per Share (EPS TTM) of Black Diamond Therapeutics Inc (BDTX) is -0.76.